180 Life Sciences Acciones en circulación
¿Qué es el Acciones en circulación de 180 Life Sciences?
El Acciones en circulación de 180 Life Sciences Corp. es 40.461M
¿Cuál es la definición de Acciones en circulación?
Las acciones en circulación son todas las acciones de una corporación o de un activo financiero que han sido autorizadas, emitidas y compradas por los inversionistas y son retenidas por ellos.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Acciones en circulación de compañías en Sector Health Care en NASDAQ en comparadas con 180 Life Sciences
¿Qué hace 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas con acciones en circulación similar a 180 Life Sciences
- Vardhman Special Steels tiene Acciones en circulación de 40.395M
- Melexis NV tiene Acciones en circulación de 40.400M
- Franklin Duration Income Trust tiene Acciones en circulación de 40.405M
- VARTA AG tiene Acciones en circulación de 40.422M
- Starboard Value Acquisition tiene Acciones en circulación de 40.424M
- CEAT tiene Acciones en circulación de 40.450M
- 180 Life Sciences tiene Acciones en circulación de 40.461M
- QuestEx Gold & Copper tiene Acciones en circulación de 40.476M
- C-COM Satellite Systems tiene Acciones en circulación de 40.486M
- 15 Split tiene Acciones en circulación de 40.494M
- ALX Oncology tiene Acciones en circulación de 40.500M
- Lancor tiene Acciones en circulación de 40.500M
- Slate Retail REIT tiene Acciones en circulación de 40.501M